分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Combinatorial photochemotherapy on liver cancer stem cells with organoplatinum(II) metallacage-based nanoparticles

Beng Yang, Hua Liu, Huang Yang, Wei Chen, Jingban Wu, Xiaode Feng, Rongliang Tong, Hanxi Yu, Yunhao Chen, Zhen Lv, Weijian Sun, Bin He, Jian Wu, Guocan Yu, Zhengwei Mao, Shusen Zheng

Journal:Journal of Materials Chemistry B

IF:5.05

DOI:10.1039/C9TB01299K

PMID:31465082

Published:2019-08-29

research field:肿瘤学药学纳米技术

Abstract

Liver cancer is a kind of lethal and aggressive malignant neoplasm with a high rate of relapse and metastasis after therapy. An important cause for the relapse and metastasis is the existence of liver cancer stem cells (CSCs), which have high resistance to chemotherapy and high tumorigenic potential. Therefore, it is crucial to develop new methods to eradicate CSCs in tumors. Herein, we develop a photodynamic therapy (PDT) that features bimodal metallacage-loaded nanoparticles (MNPs) for integrated chemotherapy. This platform achieves chemo-photodynamic combinational therapy. Organoplatinum(II) metallacage-loaded nanoparticles show excellent ability to kill liver CSCs, decreasing their mobility and sphenoid formation ability under near-infrared laser irradiation. Importantly, MNPs can successfully penetrate into 3D tumor spheroids, which display higher drug resistance compared to traditional 2D cultured cells. This destroys CSCs and prevents subsequent tumor formation in vivo. With the excellent combinational therapeutic results in hand, the working mechanisms of MNPs were then studied. MNPs under NIR light irradiation can generate reactive oxygen species (ROS), resulting in damage of mitochondrial membrane and subsequent cell apoptosis with chemotherapeutic platinum. This study proves the great potential of MNPs for combinational cancer therapy, providing a new insight for the next generation of nanomedicines.

本文使用的Yeasen产品

购物车
客服
转染试用